Abstract

ObjectivePlasma apolipoprotein (apo)D, a ubiquitously expressed protein that binds small hydrophobic ligands, is found mainly on HDL particles. According to studies of human genetics and lipid disorders, plasma apoD levels positively correlate with HDL-cholesterol and apoAI levels. Thus, we tested the hypothesis that apoD was a regulator of HDL metabolism.Methods & ResultsWe compared the plasma lipid and lipoprotein profiles of wild-type (WT) C57BL/6 mice with apoD−/− mice on a C57BL/6 background after receiving a high fat-high cholesterol diet for 12 weeks. ApoD−/− mice had higher HDL-cholesterol levels (61±13-apoD−/− vs. 52±10-WT-males; 37±11-apoD−/− vs. 22±2 WT-female) than WT mice with sex-specific changes in total plasma levels of cholesterol and other lipids. Compared to WT, the HDL of apoD−/− mice showed an increase in large, lipid-rich HDL particles and according to size various quantities and sizes of LDL particles. Plasma levels of lecithin:cholesterol acyltransferase in the control and apoD−/− mice were not different, however, plasma phospholipid transfer protein activity was modestly elevated (+10%) only in male apoD−/− mice. An in vivo HDL metabolism experiment with isolated Western-fed apoD−/− HDL particles showed that female apoD−/− mice had a 36% decrease in the fractional catabolic rate of HDL cholesteryl ester. Hepatic SR-BI and LDLR protein levels were significantly decreased; accordingly, LDL-cholesterol and apoB levels were increased in female mice.ConclusionIn the context of a high fat-high cholesterol diet, apoD deficiency in female mice is associated with increases in both plasma HDL and LDL-cholesterol levels, reflecting changes in expression of SR-BI and LDL receptors, which may impact diet-induced atherosclerosis.

Highlights

  • IntroductionPlasma low-density lipoprotein-cholesterol (LDL-C) and high-density lipoprotein (HDL)-C levels correlate positively and negatively with Cardiovascular disease (CVD) risk respectively [1, 2]

  • Cardiovascular disease (CVD) is the leading cause of death in Western countries

  • We investigated the role of apoD on high-density lipoprotein (HDL) metabolism in mice on a high fat/ cholesterol diet

Read more

Summary

Introduction

Plasma low-density lipoprotein-cholesterol (LDL-C) and high-density lipoprotein (HDL)-C levels correlate positively and negatively with CVD risk respectively [1, 2]. Statins reduce LDL-C and with it the incidence of CVD, new therapeutic options are needed to raise plasma HDL-C in ways that are atheroprotective. CETP-inhibitors raise circulating plasma HDL-C levels, but to date none have prevented CVD [3]. HDL-proteins occur as specific clusters in HDL subclasses, each exerting distinct biological functions– including regulation of cholesterol efflux, and anti-inflammatory, anti-oxidative, anti-thrombotic, and vasodilatory activities [6, 7]. Investigating the biological effects of HDL-associated proteins on the function of this lipoprotein is a key to understanding how HDL reduces CVD risk

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call